Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Agonists of liver X receptors (LXR), members of the nuclear hormone receptor superfamily, alter secretion of proinflammatory cytokines, suggesting potential antiinflammatory effects. A synthetic LXR agonist inhibited T‐cell proliferation and cytokine release in a dose‐dependent manner. Treatment of mice during induction of experimental autoimmune encephalomyelitis reduced clinical symptoms, central nervous system cellular inflammation, and major histocompatibility class II expression on microglia, as well as demyelination. In contrast to in vitro analysis, no reductions in peripheral neuroantigen specific T‐cell responses were detected in comparing ligand and vehicle treated mice. These data suggest that LXR agonists play an important protective role in the regulation of T‐cell‐mediated inflammatory disease of the central nervous system. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347 · cited 1×
“Ligand concentrations were chosen based on previous studies demonstrating the induction of LXR target genes and LXR-dependent metabolic effects in different cell types (Chawla et al., 2001; Joseph et al., 2002; Sun et al., 2003; Koldamova et al., 2005).”
MethodReciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158 · cited 8×
“LXR-mediated effects are essential for macrophage function in the immune response to microbial agents ( Joseph et al., 2004); however, LXR ligands also suppress macrophage inflammatory gene expression ( Joseph et al., 2003).”
BackgroundInfluentialImmunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
Martin, R., McFarland, H. F., & Boggs, J. M. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509084683 · Cited by 376
Apfel, R., Benbrook, D., Lernhardt, E., Ortiz, M. A., Salbert, G., & Pfahl, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.7025 · Cited by 372 · cited 2×
“Consistent with these observations and the CNS expression of both LXR subtypes (Apfel et al., 1994; Kainu et al., 1996; Repa and Mangelsdorf, 2000), LXR agonists alter gene expression within the CNS (Whitney et al.”
BackgroundKoldamova, R. P., Lefterov, I. M., Staufenbiel, M., Wolfe, D., Huang, S., Glorioso, J. C., Walter, M., Roth, M. G., & Lazo, J. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411420200 · Cited by 279
Regulation of Cholesterol Homeostasis by the Liver X Receptors in the Central Nervous System
Whitney, K. D., Watson, M. A., Collins, J. L., Benson, W. G., Stone, T. M., Numerick, M. J., Tippin, T. K., Wilson, J. G., Winegar, D. A., & Kliewer, S. A. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.6.0835 · Cited by 211
Expression of Liver X Receptor Target Genes Decreases Cellular Amyloid β Peptide Secretion
Sun, Y., Yao, J., Kim, T.-W., & Tall, A. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300760200 · Cited by 179 · cited 1×
“Ligand concentrations were chosen based on previous studies demonstrating the induction of LXR target genes and LXR-dependent metabolic effects in different cell types (Chawla et al., 2001; Joseph et al., 2002; Sun et al., 2003; Koldamova et al., 2005).”
Method
Cited by
The aryl hydrocarbon receptor: multitasking in the immune system
Stockinger, B., Meglio, P. D., Gialitakis, M., & Duarte, J. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120245 · Cited by 909
Integration of metabolism and inflammation by lipid-activated nuclear receptors
Bensinger, S. J., & Tontonoz, P. (2008) · Nature · doi:10.1038/nature07202 · Cited by 810
LXR signaling couples sterol metabolism to proliferation in the acquired immune response
Bensinger, S. J., Bradley, M. N., Joseph, S. B., Zelcer, N., Janssen, E. M., Hausner, M. A., Shih, R., Parks, J. S., Edwards, P. A., Jamieson, B. D., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.052 · Cited by 711
A-Gonzalez, N., Bensinger, S. J., Hong, C., Beceiro, S., Bradley, M. N., Zelcer, N., Deniz, J., Ramirez, C., Díaz, M., Gallardo, G., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.018 · Cited by 677
Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors
Zelcer, N., Khanlou, N., Clare, R., Jiang, Q., Reed-Geaghan, E. G., Landreth, G. E., Vinters, H. V., & Tontonoz, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701096104 · Cited by 358
Liver X receptor biology and pharmacology: new pathways, challenges and opportunities
Jakobsson, T., Treuter, E., Gustafsson, J.-Å., & Steffensen, K. R. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.013 · Cited by 302
Sterols and oxysterols in immune cell function
Spann, N. J., & Glass, C. K. (2013) · Nature Immunology · doi:10.1038/ni.2681 · Cited by 297
Fernández-Calle, R., Konings, S. C., Frontiñán-Rubio, J., García-Revilla, J., Camprubí-Ferrer, L., Svensson, M., Martinson, I., Boza-Serrano, A., Venero, J. L., Nielsen, H. M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00566-4 · Cited by 278
Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation
Cui, G., Qin, X., Wu, L., Zhang, Y., Sheng, X., Yu, Q., Sheng, H., Xi, B., Zhang, J. Z., & Zang, Y. Q. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42974 · Cited by 271
Kumar, N., Solt, L. A., Conkright, J. J., Wang, Y., Istrate, M. A., Busby, S. A., Garcia-Ordonez, R. D., Burris, T. P., & Griffin, P. R. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.060905 · Cited by 236
“For example, T0901317 has been used to show that activation of LXR may lead to decreased severity of experimental autoimmune encephalomyelitis (Hindinger et al., 2006) by decreasing Th17 function (Xu et al., 2009).”
MethodTargeting liver X receptors in cancer therapeutics
Lin, C.-Y., & Gustafsson, J.-Å. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3912 · Cited by 172
Cholesterol metabolism in Huntington disease
Karasinska, J. M., & Hayden, M. R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.132 · Cited by 154
Liver X receptors as regulators of macrophage inflammatory and metabolic pathways
A-González, N., & Castrillo, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.015 · Cited by 139
“Recent studies have also explored a potential impact of LXRs in the brain with special focus on some inflammatory conditions in models of Alzheimer's disease [140,141], experimental autoimmune encephalitis (EAE)[142] or ischemic stroke [141,143– 146].”
BackgroundLiver X receptors alpha and beta promote myelination and remyelination in the cerebellum
Meffre, D., Shackleford, G., Hichor, M., Gorgievski, V., Tzavara, E. T., Trousson, A., Ghoumari, A. M., Deboux, C., Nait Oumesmar, B., Liere, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424951112 · Cited by 114
“attenuates the inflammatory process to reduce the severity of the pathology (21, 22).”
BackgroundStructure of the retinoid X receptor α-liver X receptor β (RXRα-LXRβ) heterodimer on DNA
Lou, X., Toresson, G., Benod, C., Suh, J. H., Philips, K. J., Webb, P., & Gustafsson, J.-A. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2778 · Cited by 105
ABCA1 influences neuroinflammation and neuronal death
Karasinska, J. M., de Haan, W., Franciosi, S., Ruddle, P., Fan, J., Kruit, J. K., Stukas, S., Lütjohann, D., Gutmann, D. H., Wellington, C. L., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.018 · Cited by 104
Pascual-García, M., Rué, L., León, T., Julve, J., Carbó, J. M., Matalonga, J., Auer, H., Celada, A., Escolà-Gil, J. C., Steffensen, K. R., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201393 · Cited by 51
Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2
Secor McVoy, J. R., Oughli, H. A., & Oh, U. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0247-2 · Cited by 34
“A previous study tested a different LXR agonist (T091317) during the effector phase of EAE [38].”
MethodJan, A., Karasinska, J. M., Kang, M. H., de Haan, W., Ruddle, P., Kaur, A., Connolly, C., Leavitt, B. R., Sorensen, P. H., & Hayden, M. R. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.05.007 · Cited by 28
Cholesterol Metabolism in CNS Diseases: The Potential of SREBP2 and LXR as Therapeutic Targets
Wang, N.-Q., Sun, P.-X., Shen, Q.-Q., & Deng, M.-Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04672-w · Cited by 19
“…limited investigation into Oligodendrocytes prepared from male LXR dKO mice [175] Reduces clinical symptoms and inhibits demy-elination EAE mice [191] GW3965 Promoting myelin regeneration by rescuing inefficient cholesterol efflux and ameliorating the inflammatory response in the aged central…”
Metadata
- Authors
- Hindinger, C., Hinton, D. R., Kirwin, S. J., Atkinson, R. D., Burnett, M. E., Bergmann, C. C., & Stohlman, S. A.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2006-09-05
- Volume
- 84
- Issue
- 6
- Pages
- 1225-1234
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2118140890
- Cited by
- 101
- References
- 8
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.